Clinical Trials Browser

Has results × spartalizumab × Plasma cell × Clear all

NCT02331368 2018-07-27

Phase 2 Multi-center Study of Anti-PD-1 During Lymphopenic State After HDT/ASCT for Multiple Myeloma

Phase 2 Completed

32 enrolled 8 charts

Multiple Myeloma